117 related articles for article (PubMed ID: 8100201)
1. Elevated CEA in breast cancer patients with overlooked medullary thyroid carcinoma.
Andry G; Wildschutz T; Chantrain G; Bonnyns M; Dor P
Eur J Surg Oncol; 1993 Jun; 19(3):305-8. PubMed ID: 8100201
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
3. [Histological identification of carcinoembryonic antigen in breast cancer. Use of an immunohistochemical technique in 71 cases of breast cancer (author's transl)].
Bonetti F; Maconi A; Pisa R; Menestrina F; Novelli P; Iannucci A; Chilosi M; Rasniewskij K
Pathologica; 1981; 73(1026):639-47. PubMed ID: 6273781
[No Abstract] [Full Text] [Related]
4. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
5. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
Roof BS; Weinstein R; Vujic I; Burdash NM
Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
[TBL] [Abstract][Full Text] [Related]
6. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry in medullary thyroid carcinoma: prognosis and distinction between hereditary and sporadic tumors.
Franc B; Caillou B; Carrier AM; Dutrieux-Berger N; Floquet J; Houcke M; Justrabo E; Lange F; Pages A; Rigaud C
Henry Ford Hosp Med J; 1987; 35(2-3):139-42. PubMed ID: 2891646
[No Abstract] [Full Text] [Related]
8. [CEA, grade and stage in breast carcinoma. Immunohistochemical study of 40 cases].
Sironi M; Cantaboni A
Pathologica; 1984; 76(1044):427-36. PubMed ID: 6096797
[No Abstract] [Full Text] [Related]
9. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
10. The use of octreotide in the treatment of medullary thyroid carcinoma.
Frank-Raue K; Ziegler R; Raue F
Horm Metab Res Suppl; 1993; 27():44-7. PubMed ID: 8330871
[TBL] [Abstract][Full Text] [Related]
11. [Ectopic hormone formation in multiple endocrine type IIa neoplasia (author's transl)].
Weber T; Cordes U; Eberle S; Rothmund M; Krause U; Beyer J
Dtsch Med Wochenschr; 1982 Feb; 107(7):252-6. PubMed ID: 6120065
[TBL] [Abstract][Full Text] [Related]
12. Medullary thyroid carcinoma experienced at Kanazawa University Hospital.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ohtake S; Nakamura S; Ishizaki T
J Surg Oncol; 1996 Jan; 61(1):27-33. PubMed ID: 8544456
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of lymph-node metastases by anti-CEA immunoscintigraphy in a patient with follicular thyroid and breast cancer.
Lind P; Lechner P; Kuttnig M; Klimpfinger M; Langsteger W; Költringer P; Cesnik H; Eber O
Nuklearmedizin; 1990 Dec; 29(6):278-81. PubMed ID: 1963681
[TBL] [Abstract][Full Text] [Related]
14. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
15. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
16. [Initial immunologic evaluations in breast and thyroid cancer].
Abeatici S; Mussa A; Levis P; Sandrucci S; Storta P
Minerva Med; 1982 Apr; 73(18):1149-54. PubMed ID: 6979010
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of carcinoembryonic antigen level of serum and tumor tissue in breast cancer patients (author's transl)].
Kitamura M; Tominaga T; Kaneko H; Hayashi K; Takahashi I; Saito T; Ito I
Nihon Gan Chiryo Gakkai Shi; 1981 Feb; 16(1):35-43. PubMed ID: 6267147
[No Abstract] [Full Text] [Related]
18. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
19. [A case of multiple endocrine neoplasia (MEN), type 2A. Immunohistochemical and ultrastructural study of medullary carcinoma of the thyroid].
Tabuse Y; Tabuse K; Kawaguchi T; Kodama E; Katsumi M; Hiraoka J; Ohno T
Nihon Geka Hokan; 1983 Sep; 52(5):736-43. PubMed ID: 6144294
[No Abstract] [Full Text] [Related]
20. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
Machens A; Ukkat J; Hauptmann S; Dralle H
Arch Surg; 2007 Mar; 142(3):289-93; discussion 294. PubMed ID: 17372055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]